Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models
2017 ◽
Vol 174
(9)
◽
pp. 822-835
◽
1995 ◽
Vol 5
(3)
◽
pp. 223-228
◽
1994 ◽
Vol 256
(1)
◽
pp. 109-112
◽
1999 ◽
Vol 273
(3)
◽
pp. 191-194
◽
2017 ◽
Vol 45
(7)
◽
pp. 912-921
◽
1996 ◽
Vol 207
(1)
◽
pp. 70-72
◽
2016 ◽
Vol 45
(2)
◽
pp. 137-144
◽